Projekt · Dnr 2020-03601 · Källa: Vinnova
E!114537, PROPEL, Uppsala Universitet
- Koordinator
- Uppsala universitet, Institutionen för kemi - Ångström
- Projekttid
- 2020-10-01 till 2023-01-01 (avslutat)
- Beviljat bidrag
- 1 949 953 SEK
- Diarienummer
- 2020-03601
Beskrivning
To determine the invitro therapeutic efficacy of chemically (guanidinium) modified siRNA we have designed a post-synthetic chemically (guanidinium) modified oligonucleotide through hydrazone linkage. As a proof of concept, we introduced our aldehyde modification on STAT3 and CHMP targeting siRNAs with variable aldehydes on the overhang positions. The aldehyde-modified oligonucleotides were subjected to condensation with hydrazide moiety which is linked with guanidinium units and shown a potential gene knockdown capability in cancer cells. We have developed a universal chemical modification strategy to synthesize chemically modified oligonucleotides through post-synthetic modification. In this work, we have synthesized siRNAs with variable aldehyde functionalities which allows the chemical functionalization of any molecule of interest through hydrazone chemistry. We tested this chemical modification on two different siRNAs which showed a comparable knockdown in targeted genes.
Hittar Vinnova inte sidan? Sök på diarienumret hos Vinnova.
Liknande
-
Innovative Strategy for Targeted Delivery of Precision Medicine Drugs (INSPIRE)
Uppsala Therapeutics AB · 2021-05-01 · 1 918 560 SEK · Projekt
The aim of the project was to synthesize chemically modified oligonucleotides that are sensitive to stimuli like alkaline phosphatase and esterase. We have developed esterase-sensitive drug-siRNA conjugates and alkaline-sensitive chemically modified siRNA and DisiRNA. All our siRNAs are functional i…
-
E!11481, E-OxidoCurin, HDXperts AB
HDxperts AB · 2017-10-01 · 4 888 259 SEK · Projekt
All the goals of the project were fulfilled. 1) A new water-soluble lead compound LCTA2940 was synthesized. 2) The TrxR1 target was validated, and the mechanism of interaction and ROS dependent action was elucidated. 3) Using proteomics, we identified additional targets. 4) In vivo LCTA2940 effectiv…
-
Enrichment reagents for NGS
Kungliga Tekniska högskolan · 2026-04-21 · sista anbudsdag 2026-05-25 · 20 000 000 SEK · Upphandling
Royal Institute of Technology (KTH ) hereby invites suppliers to submit a tender for design of custom panels and deliver of custom panels for targeted sequencing using NGS (Next Generation Sequencing) on a small scale.
-
Enrichment reagents for NGS
Kungliga Tekniska högskolan · 2026-05-21 · sista anbudsdag 2026-06-02 · 20 000 000 SEK · Upphandling
Royal Institute of Technology (KTH ) hereby invites suppliers to submit a tender for design of custom panels and deliver of custom panels for targeted sequencing using NGS (Next Generation Sequencing) on a small scale.
-
Enrichment reagents for NGS
Kungliga Tekniska högskolan · 2026-06-25 · 20 000 000 SEK · Tilldelning
Royal Institute of Technology (KTH ) hereby invites suppliers to submit a tender for design of custom panels and deliver of custom panels for targeted sequencing using NGS (Next Generation Sequencing) on a small scale.